| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1a9ce67c61dab361d42e877597948fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_473771ee5d1dad81cd9167599aa3f1eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d129195d35f178edd75fb75e7d8f5fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2001-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abc1ff54c81767b00470e5a85549e981
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8789e453e3779bead4ea78a62ffc83a6 |
| publicationDate |
2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0222175-A2 |
| titleOfInvention |
Method and composition for treating tumors by selective induction of apoptosis |
| abstract |
Compositions and methods are provided for inducing death of cancer cells through apotposis mediated by the death ligand, TRAIL. The method comprising: introducing an expression vector into a group of cells comprising cells that express a receptor for TRAIL. The expression vector comprises a polynucleotide sequence encoding TRAIL whose expression is preferably regulated by a conditional promoter in the vector. The cells into which the expression vector is introduced express TRAIL when conditions are suitable to activate the conditional promoter. The expressed TRAIL induces cell death in those cells which express the TRAIL receptor through interaction between TRAIL and the receptor such as DR4 and DR5. The method can be used for treating tumors site-specifically and in a dose-adjustable manner. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101144081-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9428565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105126120-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9605074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9862932-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006010558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014205516-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10030057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8697379-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3682873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8093393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10633636-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014086907-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1621550-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018176027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105126120-A |
| priorityDate |
2000-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |